Telerehabilitation exercise program after lung cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates a therapist-guided telerehabilitation exercise program delivered remotely to adults who recently had thoracic surgery for lung cancer. Participants are assigned to either the telerehabilitation program or usual postoperative care to see if the remote exercise approach improves physical function and reduces symptoms such as dyspnea and fatigue. The program leverages smartphones or computers to provide exercise sessions and clinical follow-up, aiming to improve access to rehabilitation and support safe, quicker recovery. Outcomes focus on functional capacity, quality of life, and postoperative complications, within a real-world Andalusian care setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 to 80 years.
* Histologically confirmed primary lung cancer (stage 0 to IIIB).
* Patients who have undergone thoracic surgery for lung cancer.
* Medical clearance to participate in an exercise-based rehabilitation program.
* Ability to understand and communicate verbally.
* Access to a smartphone and/or computer with internet connection.

Exclusion Criteria:

* Any medical condition or comorbidity that contraindicates participation in an exercise program.
* Current psychiatric disorder that may interfere with study participation.
* Inability to provide written informed consent.
* Previous thoracic surgery.
* History of another malignancy within the past one year.

Where it's running

• Hospital Universitario Virgen Macarena
  Seville, Andalusia, Spain Recruiting

Study contacts

• Principal investigator: María Jesús Casuso Holgado — University of Seville
• Study coordinator: David Ortega Valle, PT, MSc
• Email: davortval@alum.us.es
• Phone: 663616650

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

  This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

  Recruiting Chest Diseases Hospital, Ministry of Health, Kuwait · Kuwait City · NCT07766538

• Nitride-based Raman biochip for lung cancer diagnosis and monitoring

  A large observational study in Taiwan will test whether a blood-based nitride-based Raman biochip can help diagnose lung cancer and monitor patients over time.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07755020

• Modified Arm Positioning to Reduce Shoulder Pain After Thoracoscopic Lobectomy

  This trial tests whether changing how the arm is positioned during thoracoscopic lobectomy can lower shoulder pain on the operated side in adults with lung lesions.

  Recruiting Chengdu Jinjiang Maternity and Child Health Hospital · Chengdu, Sichuan · NCT07746323

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.